JPH05239040A - Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor - Google Patents

Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor

Info

Publication number
JPH05239040A
JPH05239040A JP4117692A JP4117692A JPH05239040A JP H05239040 A JPH05239040 A JP H05239040A JP 4117692 A JP4117692 A JP 4117692A JP 4117692 A JP4117692 A JP 4117692A JP H05239040 A JPH05239040 A JP H05239040A
Authority
JP
Japan
Prior art keywords
formula
group
represented
hydroxymethyl
isoxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP4117692A
Other languages
Japanese (ja)
Inventor
Akihiro Isaka
坂 明 洋 井
Kunio Kageyama
山 邦 夫 影
Shoichiro Ozaki
崎 庄一郎 尾
Takahiko Akiyama
山 隆 彦 秋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yokohama Rubber Co Ltd
Original Assignee
Yokohama Rubber Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yokohama Rubber Co Ltd filed Critical Yokohama Rubber Co Ltd
Priority to JP4117692A priority Critical patent/JPH05239040A/en
Publication of JPH05239040A publication Critical patent/JPH05239040A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To easily obtain the subject optically active compound in high efficiency without the need for optical resolution. CONSTITUTION:Firstly, an acrylic ester derivative of formula I [R<1> is SiR3 (R3 is alkyl or aromatic group)] is made to react with a nitrile oxide of formula II (R<2> is alkyl or aromatic group) to form a mixture of isoxazoline derivatives of respective formula III and formula IV. This mixture is then separated by e.g. chromatography and the ester groups of the respective compounds are reduced (e.g. by the action of L-selectolide, an ester-reducing reagent) to obtain a (S)-5-hydroxymethyl-2-isoxazoline compound of formula V from the compound of the formula III and a (R)-5-hydroxymethyl-2-isoxazoline compound of formula VI from the compound of the formula IV. The compound of the formula I is a new compound, and can be obtained by esterification between an inositol derivative of formula VII and acrylic acid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は5−ヒドロキシメチル−
2−イソオキサゾリン類の製造方法及びその製造に用い
る中間体としての新規イソオキサゾリン誘導体、更には
該イソオキサゾリン誘導体の製造方法及びイソオキサゾ
リン誘導体の製造に用いる中間体としての新規アクリル
エステル誘導体に関する。
The present invention relates to 5-hydroxymethyl-
The present invention relates to a method for producing 2-isoxazolines, a novel isoxazoline derivative as an intermediate used in the production, and a method for producing the isoxazoline derivative and a novel acrylic ester derivative as an intermediate used in the production of the isoxazoline derivative.

【0002】[0002]

【発明の背景】ニトリルオキシドとアルケンの環状付加
反応によって得られるΔ2 −イソオキサゾリン類は、β
−ヒドロキしケトンや1,3−アミノアルコールなどの
種々の化合物の原料になり、これらの光学活性体は更な
る用途の拡大が期待されている。
BACKGROUND OF THE INVENTION Δ 2 -Isoxazolines obtained by the cycloaddition reaction of nitrile oxides and alkenes are β
-It is a raw material for various compounds such as hydroxyketone and 1,3-aminoalcohol, and these optically active substances are expected to have further expanded applications.

【0003】従来知られている(S)−5−ヒドロキシ
メチル−2−イソオキサゾリンの合成方法としては W.O
ppolzer らによる方法がある(Tetrahedron Letter, 32
No.37, pp 4893-4896(1991)参照) 。
A conventionally known method for synthesizing (S) -5-hydroxymethyl-2-isoxazoline is WO
There is a method by ppolzer et al. (Tetrahedron Letter, 32
No. 37, pp 4893-4896 (1991)).

【0004】この方法は(S)−5−ヒドロキシメチル
−2−イソオキサゾリンを合成するための不斉補助基を
得るために、まずラセミ体の化合物を合成し、これと
(1S)−10−カンファースルホン酸との塩を作り、
光学分割することでR体の不斉補助基を得ることからな
る。しかし、より簡便に光学活性な5−ヒドロキシメチ
ル−2−イソオキサゾリン類を製造する方法の出現が望
まれている。
According to this method, in order to obtain an asymmetric auxiliary group for synthesizing (S) -5-hydroxymethyl-2-isoxazoline, a racemic compound is first synthesized and then (1S) -10- Make a salt with camphorsulfonic acid,
It consists of obtaining an R-form asymmetric auxiliary group by optical resolution. However, the appearance of a method for more easily producing optically active 5-hydroxymethyl-2-isoxazolines is desired.

【0005】[0005]

【発明の目的】本発明は光学活性を有するβ−ヒドロキ
シケトンや1,3−アミノアルコールなど抗生物質の原
料として用いられる(S)−5−ヒドロキシメチル−2
−イソオキサゾリン類及び(R)−5−ヒドロキシメチ
ル−2−イソオキサゾリン類の製造方法、これら光学活
性物質の製造に用いる中間体としての新規イソオキサゾ
リン誘導体、該イソオキサゾリン誘導体の製造方法及び
イソオキサゾリンの製造に用いる中間体としての新規ア
クリルエステル誘導体の提供を目的とする。
The object of the present invention is to use (S) -5-hydroxymethyl-2 as a raw material for antibiotics such as optically active β-hydroxyketone and 1,3-aminoalcohol.
-Methods for producing isoxazolines and (R) -5-hydroxymethyl-2-isoxazolines, novel isoxazoline derivatives as intermediates used for producing these optically active substances, methods for producing the isoxazoline derivatives and isoxazolines An object of the present invention is to provide a novel acrylic ester derivative as an intermediate used in the production of

【0006】[0006]

【発明の構成】本発明によれば、下記構造式(1)で示
されるイソオキサゾリン誘導体を
According to the present invention, an isoxazoline derivative represented by the following structural formula (1)

【化9】 (但しここでR1 は−SiR3 で示される有機シリル基
で、Rはアルキル基又は芳香族基であり、R2 はアルキ
ル基又は芳香族基である。以下の構造式に於いても同意
である。)。 還元することを特徴とする下記構造式(2)で示される
(S)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法
[Chemical 9] (Here, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group. It is.). A method for producing (S) -5-hydroxymethyl-2-isoxazolines represented by the following structural formula (2), which comprises reducing

【化10】 及び、下記構造式(3)で示されるイソオキサゾリン誘
導体を
[Chemical 10] And an isoxazoline derivative represented by the following structural formula (3)

【化11】 還元することを特徴とする構造式(4)で示される
(R)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法が提供される。
[Chemical 11] There is provided a method for producing (R) -5-hydroxymethyl-2-isoxazolines represented by structural formula (4), which comprises reducing.

【化12】 [Chemical 12]

【0007】更に、上記製造方法に於いて原料として用
いられる中間体としての上記式(1)又は(3)で示さ
れる新規イソオキサゾリン誘導体が提供される。
Further, there is provided a novel isoxazoline derivative represented by the above formula (1) or (3) as an intermediate used as a raw material in the above production method.

【0008】さらには該新規イソオキサゾリン誘導体の
製造方法として、下記構造式(5)で示されるアクリル
エステル誘導体に
Further, as a method for producing the novel isoxazoline derivative, an acrylic ester derivative represented by the following structural formula (5) is used.

【化13】 2 −C≡N+ −O- で示されるニトリルオキシドを反
応させることを特徴とする構造式(1)又は(3)で示
されるイソオキサゾリン誘導体の製造方法が提供され、
加えてこの製法の原料として用いる新規中間体物質(上
記式(5))が提供される。
[Chemical 13] A method for producing an isoxazoline derivative represented by Structural Formula (1) or (3), which comprises reacting a nitrile oxide represented by R 2 -C≡N + —O ,
In addition, a novel intermediate substance (the above formula (5)) used as a raw material of this production method is provided.

【0009】以下、本発明の構成を詳述するが、本発明
のより好ましい態様及びそれに基づく利点がより明確に
なるであろう。
Hereinafter, the constitution of the present invention will be described in detail, but more preferable embodiments of the present invention and advantages based on them will become clearer.

【0010】イソオキサゾリン誘導体 前記構造式(1)及び(3)のイソオキサゾリン誘導体
に於いてR1 は−SiR3 で示される有機シリル基であ
り、Rはアルキル基又は芳香族基で、炭素数1〜10の
ものが好ましく、特には1〜6のものが好ましい。アル
キル基として具体的には、メチル基、エチル基、プロピ
ル基、イソプロピル基、ブチル基、s−ブチル基、t−
ブチル基、ペンチル基、ヘキシル基などを好ましく例示
できる。又、芳香族基としてはフェニル基、メチルフェ
ニル基などを好ましく例示することができる。
Isoxazoline Derivatives In the isoxazoline derivatives of the above structural formulas (1) and (3), R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and the number of carbon atoms is Those having 1 to 10 are preferable, and those having 1 to 6 are particularly preferable. Specific examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a s-butyl group and a t- group.
A butyl group, a pentyl group, a hexyl group and the like can be preferably exemplified. Further, as the aromatic group, a phenyl group, a methylphenyl group and the like can be preferably exemplified.

【0011】有機シリル基である-SiR3 の好適な例とし
て、-Sit-BuMe2,-Sit-BuPh2などを挙げることができ
る。
Preferred examples of -SiR 3 which is an organic silyl group include -Sit-BuMe 2 and -Sit-BuPh 2 .

【0012】構造式(1)及び(2)に於いて、R2
アルキル基又は芳香族基であり、炭素数4〜6のものが
好ましい。好ましい具体例としてフェニル基、t−ブチ
ル基、イソプロピル基、エチル基、メチル基などを例示
することができる。構造式(1)及び(3)に於いてR
1 とR2 の好適な組み合わせを表1として示す。
In the structural formulas (1) and (2), R 2 is an alkyl group or an aromatic group and preferably has 4 to 6 carbon atoms. Preferred examples include phenyl group, t-butyl group, isopropyl group, ethyl group, methyl group and the like. R in structural formulas (1) and (3)
A suitable combination of 1 and R 2 is shown in Table 1.

【0013】 [0013]

【0014】構造式(1)及び(3)で示される化合物
はジアステレオマーの関係にあるので混合物であっても
例えばクロマトグラフィーを利用して容易に分離するこ
とができる。
Since the compounds represented by the structural formulas (1) and (3) have a diastereomeric relationship, even a mixture can be easily separated by using, for example, chromatography.

【0015】構造式(1)及び(3)のイゾオキサゾリ
ン誘導体は後に詳述する方法でアクリルエステル誘導体
(5)とニトリルオキシドとの反応によって得られる
が、その場合イソオキサゾリン誘導体(1)と(3)の
混合物として取得される。この混合物は前述のようにク
ロマトグラフィーの手法によって分離可能である。
The isoxazoline derivatives of the structural formulas (1) and (3) can be obtained by reacting an acrylic ester derivative (5) with a nitrile oxide by a method described in detail later, in which case isoxazoline derivatives (1) and ( Obtained as a mixture of 3). This mixture can be separated by chromatographic techniques as described above.

【0016】イソオキサゾリン誘導体の還元 イソオキサゾリン誘導体(1)又は(3)のエステル基
を還元することにより各々対応する光学活性な式(2)
又は式(4)で示される5−ヒドロキシメチル−2−イ
ソオキサゾリン類を生成する。
Reduction of isoxazoline derivative By reducing the ester group of the isoxazoline derivative (1) or (3), the corresponding optically active formula (2) is obtained.
Alternatively, 5-hydroxymethyl-2-isoxazolines represented by the formula (4) are produced.

【0017】還元する方法としては、例えばエステル還
元試薬であるL−セレクトライド(L-selectride) をイ
ソオキサゾリン誘導体(1)に作用させる方法(ここで
L−セレクトライドとはリチウムトリ−sec−ブチル
ポロハイドライド LiB[CH(CH 3)C2H5]3H である)などの
方法が挙げられる。
Examples of the reduction method include ester reduction.
The original reagent, L-selectride,
Method of acting on soxazoline derivative (1) (here
What is L-Selectride? Lithium tri-sec-butyl
Polo hydride LiB [CH (CH 3) C2HFive]3H) etc.
There is a method.

【0018】L−セレクトライドを用いる場合、イソオ
キサゾリン誘導体(1)のテトラヒドロフラン溶液中に
4〜5モル倍のL−セレクトライドを添加し、半日程度
攪拌することにより(S)−5−ヒドロキシ−2−イソ
オキサゾリン類(式(2))が生成するので、反応混合
物をクロマトグラフィーにより分離して目的物を得るこ
とができる。
When L-selectride is used, 4-5 mol times of L-selectride is added to a tetrahydrofuran solution of the isoxazoline derivative (1), and the mixture is stirred for about half a day to obtain (S) -5-hydroxy-. Since 2-isoxazolines (formula (2)) are produced, the reaction mixture can be separated by chromatography to obtain the desired product.

【0019】このような方法で製造できる光学活性な5
−ヒドロキシメチル−2−オキサゾリン類の具体例とし
ては、以下のものが例示される。(S)−5−ヒドロキシメチル−2−オキサゾリン類
(式(2)) (S)−5−ヒドロキシメチル−3−フェニル−2−イ
ソオキサゾリン (S)−5−ヒドロキシメチル−3−t−ブチル−2−
イソオキサゾリン(R)−5−ヒドロキシメチル−2−オキサゾリン類
(式(3)) (R)−5−ヒドロキシメチル−3−フェニル−2−イ
ソオキサゾリン (R)−5−ヒドロキシメチル−3−t−ブチル−2−
イソオキサゾリン
Optically active 5 which can be produced by such a method
Specific examples of -hydroxymethyl-2-oxazolines include the following. (S) -5-Hydroxymethyl-2-oxazolines
(Formula (2)) (S) -5-hydroxymethyl-3-phenyl-2-isoxazoline (S) -5-hydroxymethyl-3-t-butyl-2-
Isoxazoline (R) -5-hydroxymethyl-2-oxazolines
(Formula (3)) (R) -5-hydroxymethyl-3-phenyl-2-isoxazoline (R) -5-hydroxymethyl-3-t-butyl-2-
Isoxazoline

【0020】しかしながら本発明に於いては式(2)の
(S)の立体配置を有する光学異性体を効率良く製造す
ることができる。
However, in the present invention, the optical isomer having the configuration of (S) of formula (2) can be efficiently produced.

【0021】オキサゾリン誘導体の製造 オキサゾリン誘導体(1)及び(3)は、前記構造式
(5)で示されるアクリルエステル誘導体とR2 −C≡
+ −O- で示されるニトリルオキシドとを反応させる
ことにより製造することができる。式(5)に於けるR
1 及びニトリルオキシドのR2 の定義及び好ましい態様
はオキサゾリン誘導体(1)及び(3)について述べた
場合と同様である。ニトリルオキシドは対応する下式
(6)で示されるヒドロオキシム酸ハロゲン化合物を塩
基雰囲気下に置くと脱ハロゲン化水素することにより生
成する。
Production of Oxazoline Derivatives The oxazoline derivatives (1) and (3) are the same as the acrylic ester derivative represented by the structural formula (5) and R 2 -C≡.
It can be produced by reacting with a nitrile oxide represented by N + —O . R in equation (5)
The definition and preferred embodiments of R 2 of 1 and nitrile oxide are the same as those described for the oxazoline derivatives (1) and (3). Nitrile oxide is produced by dehydrohalogenating a corresponding hydroxyoxime acid halogen compound represented by the following formula (6) under a basic atmosphere.

【0022】[0022]

【化14】 (X;ハロゲン)[Chemical 14] (X; halogen)

【0023】従って、上記反応アクリルエステル誘導体
(5)1モルに対してヒドロオキシム酸ハロゲン化物を
5モル程度用いて適切な溶媒中と、トリエチルアミンな
どの塩基物質の存在下に行うことにより、反応系にニト
リルオキシドが生成し、反応が進行する。
Therefore, the reaction system is prepared by using about 5 mol of the hydroxyoxime halide per 1 mol of the reaction acrylic ester derivative (5) in a suitable solvent and in the presence of a basic substance such as triethylamine. Nitrile oxide is generated in the reaction and the reaction proceeds.

【0024】使用できる溶媒はベンゼン、トルエン、テ
トラヒドロフラン、アセトニトリルエーテル及びジクロ
ロメタンなどを好ましく挙げられる。塩基物質はハロゲ
ン化水素を補足できる程度の量、即ち化合物(6)と当
量あるいはそれよりも若干多い量用いればよい。この様
にしてイソオキサゾリン誘導体(1)及び(2)が生成
するが、その生成割合はR1 の種類によって異り、R1
がバルキーであるとイソオキサゾリン誘導体(1)の生
成割合が大となる、即ちジアステレオー選択性が大とな
る。本発明に於いては生成割合((1)/(3))は9
5/5〜70/30の範囲であるが使用する溶媒、反応
温度によってもその割合は影響を受ける。
The solvent which can be used is preferably benzene, toluene, tetrahydrofuran, acetonitrile ether, dichloromethane or the like. The basic substance may be used in an amount sufficient to capture hydrogen halide, that is, in an amount equivalent to or slightly higher than that of the compound (6). Although isoxazoline derivative (1) and (2) is formed in this manner, the generation ratio Ili depending on the type of R 1, R 1
Is bulky, the production rate of the isoxazoline derivative (1) is high, that is, diastereoselectivity is high. In the present invention, the production ratio ((1) / (3)) is 9
The ratio is in the range of 5/5 to 70/30, but the ratio is affected by the solvent used and the reaction temperature.

【0025】従って、この反応はイソオキサゾリン誘導
体(1)を収率良く得る方法として有利である。
Therefore, this reaction is advantageous as a method for obtaining the isoxazoline derivative (1) in good yield.

【0026】アクリルエステル誘導体 アクリルエステル誘導体(5)は、下記構造式(7)で
示されるイノシトール誘導体
Acrylic ester derivative The acrylic ester derivative (5) is an inositol derivative represented by the following structural formula (7).

【化15】 とアクリル酸とをエステル化反応することにより得られ
る。
[Chemical 15] It is obtained by esterifying acrylic acid with acrylic acid.

【0027】例えば、アクリル酸をアクリル酸クロリド
に一度変換後、塩基物質の存在下にイノシトール誘導体
(7)とを反応することにより極めて容易に取得するこ
とができる。
For example, it can be obtained very easily by once converting acrylic acid into acrylic acid chloride and then reacting it with the inositol derivative (7) in the presence of a basic substance.

【0028】イノシトール誘導体(7)はそれ自体公知
の物質であり、下式(8)で示される化合物とR1Clで
The inositol derivative (7) is a substance known per se, and is composed of a compound represented by the following formula (8) and R 1 Cl.

【化16】 示される化合物とを反応させることにより容易に得るこ
とができる。
[Chemical 16] It can be easily obtained by reacting with the compound shown.

【0029】アクリルエステル誘導体(5)、イノシト
ール誘導体(7)に於けるR1 は、イソオキサゾリン誘
導体(1)及び(3)について記載したことが、好まし
い態様を含めてすべてあてはまる。
As for R 1 in the acrylic ester derivative (5) and the inositol derivative (7), the descriptions in the isoxazoline derivatives (1) and (3) are all applicable including the preferable embodiment.

【0030】[0030]

【実施例】以下実施例を以って本発明を具体的に説明す
る。
EXAMPLES The present invention will be specifically described below with reference to examples.

【0031】(合成例1)1L−1,2:5,6−ジ−
O−シクロヘキシリデン−3−O−tert−ブチルジ
フェニルシリル−キロ−イノシトール(1L-1,2:5,6-Di-
O-cyclohexylidene-3-O-tert-butyldiphenylsilyl-chir
o-inositol:一般式(7)のイノシトール誘導体)の合
1L−1,2:5,6−ジ−O−シクロヘキシリデン−
キロ−イノシトール(1L-1,2:5,6-Di-O-cyclohexyliden
e-chiro-inositol)(500mg, 1.47mmol)および、イミダゾ
ール(200mg, 2.9mmol) 、tert−ブチルジフェニル
シリル クロリド(458 μl, 1.76mmol)のDMF懸濁液
(4.0 ml)を60℃で攪拌する。10%KHSO4 水溶
液を加え、反応を停止した。水層を酢酸エチルで抽出
し、有機層を飽和食塩水で洗浄した後、無水硫酸ナトリ
ウムで乾燥した。乾燥剤を濾別した後、溶媒を留去し、
得られた油状物をシリカゲルカラムクロマトグラフィー
(酢酸エチル:ヘキサン=1:20)により生成し、標
記化合物(650mg,収率:76%)を得た。
(Synthesis Example 1) 1L-1,2: 5,6-di-
O-cyclohexylidene-3-O-tert-butyldi
Phenylsilyl-kilo-inositol (1L-1,2: 5,6-Di-
O-cyclohexylidene-3-O-tert-butyldiphenylsilyl-chir
o-inositol: an inositol derivative of the general formula (7))
Compound 1L-1,2: 5,6-di-O-cyclohexylidene-
Chiro-inositol (1L-1,2: 5,6-Di-O-cyclohexyliden
A mixture of e-chiro-inositol) (500 mg, 1.47 mmol), imidazole (200 mg, 2.9 mmol) and tert-butyldiphenylsilyl chloride (458 μl, 1.76 mmol) in DMF (4.0 ml) is stirred at 60 ° C. .. The reaction was stopped by adding 10% KHSO 4 aqueous solution. The aqueous layer was extracted with ethyl acetate, the organic layer was washed with saturated saline and then dried over anhydrous sodium sulfate. After filtering off the desiccant, the solvent was distilled off,
The obtained oil was produced by silica gel column chromatography (ethyl acetate: hexane = 1: 20) to give the title compound (650 mg, yield: 76%).

【0032】1H NMR (CDCl3) δ: 1.10(9H, s, (C
H3)3), 1.09-1.72(20H, m, (CH2)10), 3.56(1H, dd, J
3,4=11.0 Hz, J2,3=5.8 Hz, H-3), 3.64(1H, dd, J3,4=
11.0 Hz,J4,5=7.0 Hz, H-4), 3.97(1H, dd, J5,4=7.0 H
z, J5,6=7.3 Hz, H-5), 4.10(1H,dd, J2,1=7.3 Hz, J
2,3=5.8 Hz, H-2), 4.21-4.30(2H, m, H-1,6), 7.32-7.
43(6H, m, aromatic), 7.65-7.75(4H, m, aromatic). [ α ]D 18 +17°(c 1.14, CHCl3).
1 H NMR (CDCl 3 ) δ: 1.10 (9H, s, (C
H 3) 3), 1.09-1.72 ( 20H, m, (CH 2) 10), 3.56 (1H, dd, J
3,4 = 11.0 Hz, J 2,3 = 5.8 Hz, H-3), 3.64 (1H, dd, J 3,4 =
11.0 Hz, J 4,5 = 7.0 Hz, H-4), 3.97 (1H, dd, J 5,4 = 7.0 H
z, J 5,6 = 7.3 Hz, H-5), 4.10 (1H, dd, J 2,1 = 7.3 Hz, J
2,3 = 5.8 Hz, H-2), 4.21-4.30 (2H, m, H-1,6), 7.32-7.
43 (6H, m, aromatic), 7.65-7.75 (4H, m, aromatic). [Α] D 18 + 17 ° (c 1.14, CHCl 3 ).

【0033】(合成例2)1L−4−O−アクリロイル−1,2:5,6−ジ−O
−シクロヘキシリデン−3−O−tert−ブチルジメ
チルシリル−キロ−イノシトール(1L-4-O-Acryloyl-1,
2:5,6-di-O-cyclohexylidene-3-O-tert-butyldimethyls
ilyl-chiro-inositol :一般式(5)のアクリルエステ
ル誘導体)の合成 一般式(7)のR1 がtert−ブチルジメチルシリル
基であるイノシトール誘導体(3.82g, 7.9mmol)とトリエ
チルアミン(3.3mL, 23.7mmol) のCH2 Cl2溶液(20m
l)に0℃でアクリル酸塩化物(1.28ml, 15.8mmol)を加え
た。0℃で1時間攪拌した後、10%KHSO4 水溶液
を加え、反応を停止する。水層を酢酸エチルで抽出し、
有機層を飽和食塩水で洗浄した後、無水硫酸ナトリウム
で乾燥する。乾燥剤を炉別した後、溶媒を留去し、得ら
れた油状物をシリカゲルカラムクロマトグラフィー(酢
酸エチル:ヘキサン=1:20) により精製し、標記化合物
(1.78g, 収率44%)を得た。
(Synthesis example 2) 1L-4-O-acryloyl-1,2: 5,6-di-O
-Cyclohexylidene-3-O-tert-butyl dime
Cylsilyl-kilo-inositol (1L-4-O-Acryloyl-1,
2: 5,6-di-O-cyclohexylidene-3-O-tert-butyldimethyls
ilyl-chiro-inositol: Acrylic ester of general formula (5)
Of the inositol derivative (3.82 g, 7.9 mmol) in which R 1 of the general formula (7) is a tert-butyldimethylsilyl group and a solution of triethylamine (3.3 mL, 23.7 mmol) in CH 2 Cl 2 (20 m
Acrylic acid chloride (1.28 ml, 15.8 mmol) was added to (l) at 0 ° C. After stirring at 0 ° C. for 1 hour, 10% KHSO 4 aqueous solution is added to stop the reaction. The aqueous layer was extracted with ethyl acetate,
The organic layer is washed with saturated saline and then dried over anhydrous sodium sulfate. After separating the desiccant by furnace, the solvent was distilled off, and the obtained oily product was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 20) to give the title compound.
(1.78 g, yield 44%) was obtained.

【0034】1H NMR (CDCl3) δ: 0.00(3H, s, CH3),
0.15(3H, s, CH3), 0.80(9H, s, (CH3)3), 1.22-1.80(2
0H, m, (CH2)10), 3.62(1H, dd, J3,4=11.3 Hz, J2,3=
7.0 Hz, H-3), 4.18(1H, dd, J2,1=6.7 Hz, J2,3=7.0 H
z, H-2), 4.22(1H, dd, J5,4=8.5 Hz, J5,6=6.1 Hz, H-
5), 4.37(1H, dd, J6,1=4.0 Hz, J6,5=6.1 Hz, H-6),4.
42(1H, dd, J6,1=4.0 Hz, J2,1=6.7 Hz, H-1), 5.08(1
H, dd, J3,4=11.3 Hz,J4,5=8.5 Hz, H-4), 5.85(1H, d
d, J=1.5 Hz, 10.4 Hz), 6.16(1H, dd, J=10.4Hz, 17.4
Hz), 6.44(1H, dd, J=1.5 Hz, 17.4 Hz). IR (neat) 2930, 2870, 1720, 1630, 1420, 1400, 135
0, 1240, 1160, 1080,1020, cm-1. [ α ]D 18 −41°(c 1.05, CHCl3).
1 H NMR (CDCl 3 ) δ: 0.00 (3H, s, CH 3 ),
0.15 (3H, s, CH 3 ), 0.80 (9H, s, (CH 3 ) 3 ), 1.22-1.80 (2
0H, m, (CH 2 ) 10 ), 3.62 (1H, dd, J 3,4 = 11.3 Hz, J 2,3 =
7.0 Hz, H-3), 4.18 (1H, dd, J 2,1 = 6.7 Hz, J 2,3 = 7.0 H
z, H-2), 4.22 (1H, dd, J 5,4 = 8.5 Hz, J 5,6 = 6.1 Hz, H-
5), 4.37 (1H, dd, J 6,1 = 4.0 Hz, J 6,5 = 6.1 Hz, H-6), 4.
42 (1H, dd, J 6,1 = 4.0 Hz, J 2,1 = 6.7 Hz, H-1), 5.08 (1
H, dd, J 3,4 = 11.3 Hz, J 4,5 = 8.5 Hz, H-4), 5.85 (1H, d
d, J = 1.5 Hz, 10.4 Hz), 6.16 (1H, dd, J = 10.4Hz, 17.4
Hz), 6.44 (1H, dd, J = 1.5 Hz, 17.4 Hz). IR (neat) 2930, 2870, 1720, 1630, 1420, 1400, 135
0, 1240, 1160, 1080,1020, cm -1 . [Α] D 18 −41 ° (c 1.05, CHCl 3 ).

【0035】(合成例3)1L−4−O−アクリロイル−1,2:5,6−ジ−O
−シクロヘキシリデン−3−O−tert−ブチルジフ
ェニルシリル−キロ−イノシトール(1L-4-O-Acryloyl-
1,2:5,6-di-O-cyclohexylidene-3-O-tert-butyldipheny
lsilyl-chiro-inositol :一般式(5)のアクリルエス
テル誘導体)の合成 合成例(1)で合成したイノシトール誘導体(0.92g, 1.
6mmol)とトリエチルアミン(3.3mL, 23.7mmol) のCH2
Cl2 溶液(20ml)に0℃で塩化アクリロイル(1.28ml, 1
5.8mmol)を加えた。0℃で1時間攪拌した後、10%K
HSO4 水溶液を加え、反応を停止した。水層を酢酸エ
チルで抽出し、有機層を飽和食塩水で洗浄した後、無水
硫酸ナトリウムで乾燥した。乾燥剤を濾別した後、溶媒
を留去し、得られた油状物をシリカゲルカラムクロマト
グラフィー(酢酸エチル:ヘキサン=1:20) により精製
し、標記化合物(0.42g, 41%)を得た。
(Synthesis Example 3) 1L-4-O-acryloyl-1,2: 5,6-di-O
-Cyclohexylidene-3-O-tert-butyldiph
Phenylsilyl-kilo-inositol (1L-4-O-Acryloyl-
1,2: 5,6-di-O-cyclohexylidene-3-O-tert-butyldipheny
lsilyl-chiro-inositol: Acrylic ester of general formula (5)
Synthesis of tellur derivative) Inositol derivative synthesized in Synthesis Example (1) (0.92g, 1.
6 mmol) and triethylamine (3.3 mL, 23.7 mmol) CH 2
Acryloyl chloride (1.28 ml, 1 ml in Cl 2 solution (20 ml) at 0 ° C.
5.8 mmol) was added. After stirring for 1 hour at 0 ° C, 10% K
Aqueous HSO 4 solution was added to stop the reaction. The aqueous layer was extracted with ethyl acetate, the organic layer was washed with saturated saline and then dried over anhydrous sodium sulfate. After the desiccant was filtered off, the solvent was distilled off, and the obtained oil was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 20) to obtain the title compound (0.42g, 41%). ..

【0036】1H NMR (CDCl3) δ: 1.00(9H, s, (C
H3)3), 1.10-1.80(20H, m, (CH2)10), 3.64(1H, dd, J
3,4=11.3 Hz, J2,3=7.3 Hz, H-3), 3.97(1H, dd, J5,4=
8.6 Hz, J 5,6=6.1 Hz, H-5), 4.26(1H, dd, J6,1=3.1 H
z, J6,5=6.1 Hz, H-6), 4.34(1H,dd, J2,1=6.4 Hz, J
2,3=7.3 Hz, H-2), 4.43(1H, dd, J6,1=3.1 Hz, J2,1=
6.4 Hz, H-1), 5.17(1H, dd, J3,4=11.3 Hz, J4,5=8.6
Hz, H-4), 5.59(1H, dd, J=1.5 Hz, 10.4 Hz), 5.77(1
H, dd, J=10.4 Hz, 17.1 Hz), 6.18(1H, dd, J=1.5 Hz,
17.1 Hz), 7.25-7.43(6H, m, aromatic), 7.51-7.60(2
H, m, aromatic), 7.70-7.78(2H, m, aromatic). IR (nujol) 3050, 1740, 1580, 1240, 1180, and 1100,
cm-1. [ α ]D 18 −44°(c 1.10, CHCl3).
[0036]1H NMR (CDCl3) δ: 1.00 (9H, s, (C
H3)3), 1.10-1.80 (20H, m, (CH2)Ten), 3.64 (1H, dd, J
3,4= 11.3 Hz, J2,3= 7.3 Hz, H-3), 3.97 (1H, dd, J5,4=
8.6 Hz, J 5,6= 6.1 Hz, H-5), 4.26 (1H, dd, J6,1= 3.1 H
z, J6,5= 6.1 Hz, H-6), 4.34 (1H, dd, J2,1= 6.4 Hz, J
2,3= 7.3 Hz, H-2), 4.43 (1H, dd, J6,1= 3.1 Hz, J2,1=
6.4 Hz, H-1), 5.17 (1H, dd, J3,4= 11.3 Hz, J4,5= 8.6
Hz, H-4), 5.59 (1H, dd, J = 1.5 Hz, 10.4 Hz), 5.77 (1
H, dd, J = 10.4 Hz, 17.1 Hz), 6.18 (1H, dd, J = 1.5 Hz,
17.1 Hz), 7.25-7.43 (6H, m, aromatic), 7.51-7.60 (2
H, m, aromatic), 7.70-7.78 (2H, m, aromatic). IR (nujol) 3050, 1740, 1580, 1240, 1180, and 1100,
 cm-1. [α]D 18 −44 ° (c 1.10, CHCl3).

【0037】(合成例4)イソオキサゾリン誘導体(1)及び(3)の合成(但
し、R1 ;Sit-BuMe2 ,R2 ;Ph) (合成例2)で合成したアクリルエステル誘導体(51mg,
0.10mmol)およびフェニルヒトロキシム酸クロリド(78m
g, 0.50mmol)ベンゼン溶液(4ml) に室温でトリエチルア
ミン(70 μl, 0.50mmol)のベンゼン溶液(3ml) を加え、
室温で1.5時間攪拌する。10%KHSO4 水溶液を
加え、反応を停止した。水層を酢酸エチルで抽出し、有
機層を飽和食塩水で洗浄した後、無水硫酸ナトリウムで
乾燥した。乾燥剤を濾別した後、溶媒を留去し、得られ
た油状物をシリカゲル薄層クロマトグラフィー(酢酸エ
チル:ヘキサン=1:10, 2回展開) により精製し、1a
(46mg)および3a(9mg) を得た。但し1aは誘導体
(1)、3aは誘導体(3)である。
Synthesis Example 4 Synthesis of isoxazoline derivatives (1) and (3) (however,
R 1 ; Sit-BuMe 2 , R 2 ; Ph) (Acrylic ester derivative (51 mg,
0.10 mmol) and phenyl human troxime acid chloride (78 m
g, 0.50 mmol) benzene solution (4 ml) at room temperature with triethylamine (70 μl, 0.50 mmol) benzene solution (3 ml),
Stir at room temperature for 1.5 hours. The reaction was stopped by adding 10% KHSO 4 aqueous solution. The aqueous layer was extracted with ethyl acetate, the organic layer was washed with saturated saline and then dried over anhydrous sodium sulfate. After the desiccant was filtered off, the solvent was distilled off, and the obtained oily substance was purified by silica gel thin layer chromatography (ethyl acetate: hexane = 1: 10, developed twice) to give 1a.
(46 mg) and 3a (9 mg) were obtained. However, 1a is a derivative (1) and 3a is a derivative (3).

【0038】1a: 1H NMR (CDCl3) δ: 0.10(3H, s, CH
3), 0.18(3H, s, CH3), 0.90(9H, s, (CH3)3), 1.12-1.
73(20H, m, (CH2)10), 3.61(1H, dd, J=11.3 Hz, 16.8
Hz),3.68(1H, dd, J3,4=11.3 Hz, J2,3=6.7 Hz, H-3),
3.72(1H, dd, J=7.3 Hz, 16.8 Hz), 4.16(1H, dd, J5,4
=8.4 Hz, J5,6=6.1 Hz, H-5), 4.20(1H, dd, J2,1=6.4
Hz, J2,3=6.7 Hz, H-2), 4.35(1H, dd, J6,1=3.7 Hz, J
6,5=6.1 Hz, H-6), 4.41(1H, dd, J6,1=3.7 Hz, J2,1=
6.4 Hz, H-1), 5.04(1H, dd, J3,4=11.3 Hz, J 4,5=8.6
Hz, H-4), 5.18(1H, dd, J=7.3 Hz, 11.3 Hz), 7.32-7.
50 (3H, m, aromatic), 7.62-7.70(2H, m, aromatic). IR (neat) 2900, 2850, 1730, 1580, 1430, 1340, 124
0, 1100, 1030, 930, 880, 750, 680, cm -1.
[0038]1a:1H NMR (CDCl3) δ: 0.10 (3H, s, CH
3), 0.18 (3H, s, CH3), 0.90 (9H, s, (CH3)3), 1.12-1.
73 (20H, m, (CH2)Ten), 3.61 (1H, dd, J = 11.3 Hz, 16.8
Hz), 3.68 (1H, dd, J3,4= 11.3 Hz, J2,3= 6.7 Hz, H-3),
3.72 (1H, dd, J = 7.3 Hz, 16.8 Hz), 4.16 (1H, dd, J5,4
= 8.4 Hz, J5,6= 6.1 Hz, H-5), 4.20 (1H, dd, J2,1= 6.4
Hz, J2,3= 6.7 Hz, H-2), 4.35 (1H, dd, J6,1= 3.7 Hz, J
6,5= 6.1 Hz, H-6), 4.41 (1H, dd, J6,1= 3.7 Hz, J2,1=
6.4 Hz, H-1), 5.04 (1H, dd, J3,4= 11.3 Hz, J 4,5= 8.6
Hz, H-4), 5.18 (1H, dd, J = 7.3 Hz, 11.3 Hz), 7.32-7.
50 (3H, m, aromatic), 7.62-7.70 (2H, m, aromatic). IR (neat) 2900, 2850, 1730, 1580, 1430, 1340, 124
0, 1100, 1030, 930, 880, 750, 680, cm-1.

【0039】3a: 1H NMR (CDCl3) δ: 0.07(3H, s, CH
3), 0.12(3H, s, CH3), 0.82(9H, s, (CH3)3), 1.30-1.
72(20H, m, (CH2)10), 3.64(1H, dd, J3,4=11.0 Hz, J
2,3=7.0 Hz, H-3), 3.65(1H, s), 3.69(1H, s), 4.17(1
H, dd, J2,1=6.4 Hz, J2,3=7.0 Hz, H-2), 4.20(1H, d
d, J5,4=8.6 Hz, J5,6=5.8 Hz, H-5), 4.40(1H, dd, J6
,1=3.1 Hz, J6,5=5.8 Hz, H-6), 4.45(1H, dd, J6,1=3.
1 Hz, J2,1=6.4 Hz, H-1), 5.03(1H, dd, J3,4=11.0 H
z, J4,5=8.6 Hz, H-4), 5.21(1H, t, J=9.5 Hz),7.33-
7.45 (3H, m, aromatic), 7.61-7.70(2H, m, aromati
c). IR (neat) 2900, 2850, 1740, 1580, 1430, 1320, 120
0, 1100, 1030, 900, 880, 750, 680, cm-1.
3a : 1 H NMR (CDCl 3 ) δ: 0.07 (3H, s, CH
3 ), 0.12 (3H, s, CH 3 ), 0.82 (9H, s, (CH 3 ) 3 ), 1.30-1.
72 (20H, m, (CH 2 ) 10 ), 3.64 (1H, dd, J 3,4 = 11.0 Hz, J
2,3 = 7.0 Hz, H-3), 3.65 (1H, s), 3.69 (1H, s), 4.17 (1
H, dd, J 2,1 = 6.4 Hz, J 2,3 = 7.0 Hz, H-2), 4.20 (1H, d
d, J 5,4 = 8.6 Hz, J 5,6 = 5.8 Hz, H-5), 4.40 (1H, dd, J 6
, 1 = 3.1 Hz, J 6,5 = 5.8 Hz, H-6), 4.45 (1H, dd, J 6,1 = 3.
1 Hz, J 2,1 = 6.4 Hz, H-1), 5.03 (1H, dd, J 3,4 = 11.0 H
z, J 4,5 = 8.6 Hz, H-4), 5.21 (1H, t, J = 9.5 Hz), 7.33-
7.45 (3H, m, aromatic), 7.61-7.70 (2H, m, aromati
c). IR (neat) 2900, 2850, 1740, 1580, 1430, 1320, 120
0, 1100, 1030, 900, 880, 750, 680, cm -1 .

【0040】(合成例5)イソオキサゾリン誘導体(1)及び(3)の合成(但
し、R1 ;Sit-BuPh2 ,R2 ;Ph) (合成例4)で合成したアクリルエステル誘導体(54mg,
0.085mmol) およびフェニルヒドロキシム酸クロリド(6
6mg, 0.43mmol)ベンゼン溶液(4ml) に室温でトリエチル
アミン(60 μl, 0.43mmol)のベンゼン溶液(3ml) を加
え、室温で1.5時間攪拌した。10%KHSO4 水溶
液を加え、反応を停止した。水層を酢酸エチルで抽出
し、有機層を飽和食塩水で洗浄した後、無水硫酸ナトリ
ウムで乾燥した。乾燥剤を濾別した後、溶媒を留去し、
得られた油状物をシリカゲル薄層クロマトグラフィー
(酢酸エチル:ヘキサン=1:10, 2回展開) により精製
し、1b(49mg)および3b(2.8mg) を得た。但し、1b
はイソオキサゾリン誘導体(1)、3bはイソオキサゾ
リン誘導体(3)である。
Synthesis Example 5 Synthesis of isoxazoline derivatives (1) and (3) (however,
R 1 ; Sit-BuPh 2 , R 2 ; Ph) (Acrylic ester derivative synthesized in Synthesis Example 4) (54 mg,
0.085 mmol) and phenylhydroxymedium chloride (6
6 mg, 0.43 mmol) benzene solution (4 ml) was added with triethylamine (60 μl, 0.43 mmol) benzene solution (3 ml) at room temperature, and the mixture was stirred at room temperature for 1.5 hours. The reaction was stopped by adding 10% KHSO 4 aqueous solution. The aqueous layer was extracted with ethyl acetate, the organic layer was washed with saturated saline and then dried over anhydrous sodium sulfate. After filtering off the desiccant, the solvent was distilled off,
The obtained oily substance was purified by silica gel thin layer chromatography (ethyl acetate: hexane = 1: 10, developed twice) to obtain 1b (49 mg) and 3b (2.8 mg). However, 1b
Is an isoxazoline derivative (1) and 3b is an isoxazoline derivative (3).

【0041】1b: 1H NMR (CDCl3) δ: 1.10(9H, s, (C
H3)3), 1.20-1.72(20H, m, (CH2)10), 3.11(1H, dd, J=
11.6 Hz, 16.8 Hz), 3.41(1H, dd, J=6.7 Hz, 16.8 H
z), 3.63(1H, dd, J3,4=11.0 Hz, J2,3=7.3 Hz, H-3),
3.94(1H, dd, J5,4=8.5 Hz, J5 ,6=5.8 Hz, H-5), 4.09
(1H, dd, J=6.7 Hz, 11.6 Hz), 4.26(1H, dd, J6,1=2.4
Hz, J6,5=5.8 Hz, H-6), 4.32(1H, dd, J2,1=6.1 Hz, J
2,3=7.3 Hz, H-2), 4.43(1H, dd, J6,1=2.4 Hz, J2,1=
6.1 Hz, H-1), 5.10(1H, dd, J3,4=11.0 Hz, J4,5=8.5
Hz, H-4), 7.29-7.45 (9H, m, aromatic), 7.50-7.62(4
H, m, aromatic),7.80-7.90(2H, m, aromatic). IR (nujol) 2900, 1850, 1740, 1580, 1440, 1360, 126
0, 1200, 1160, 1100,1040, 930, 750, 730, 690 cm-1. [ α ]D 18 +14°(c 1.07, CHCl3).
1b : 1 H NMR (CDCl 3 ) δ: 1.10 (9H, s, (C
H 3) 3), 1.20-1.72 ( 20H, m, (CH 2) 10), 3.11 (1H, dd, J =
11.6 Hz, 16.8 Hz), 3.41 (1H, dd, J = 6.7 Hz, 16.8 H
z), 3.63 (1H, dd, J 3,4 = 11.0 Hz, J 2,3 = 7.3 Hz, H-3),
3.94 (1H, dd, J 5,4 = 8.5 Hz, J 5 , 6 = 5.8 Hz, H-5), 4.09
(1H, dd, J = 6.7 Hz, 11.6 Hz), 4.26 (1H, dd, J 6,1 = 2.4
Hz, J 6,5 = 5.8 Hz, H-6), 4.32 (1H, dd, J 2,1 = 6.1 Hz, J
2,3 = 7.3 Hz, H-2), 4.43 (1H, dd, J 6,1 = 2.4 Hz, J 2,1 =
6.1 Hz, H-1), 5.10 (1H, dd, J 3,4 = 11.0 Hz, J 4,5 = 8.5
Hz, H-4), 7.29-7.45 (9H, m, aromatic), 7.50-7.62 (4
H, m, aromatic), 7.80-7.90 (2H, m, aromatic). IR (nujol) 2900, 1850, 1740, 1580, 1440, 1360, 126
0, 1200, 1160, 1100, 1040, 930, 750, 730, 690 cm -1 . [Α] D 18 + 14 ° (c 1.07, CHCl 3 ).

【0042】3b: 1H NMR (CDCl3) δ: 1.10(9H, s, (C
H3)3), 1.12-1.68(20H, m, (CH2)10), 3.25(1H, dd, J=
6.7 Hz, 16.8 Hz), 3.37(1H, dd, J=11.6 Hz, 16.8 H
z), 3.58(1H, dd, J2,3=7.6 Hz, J3,4=11.3 Hz, H-3),
3.89(1H, dd, J4,5=9.0 Hz, J5 ,6=5.8 Hz, H-5), 4.25-
4.38(3H, m, H-2.6, ring), 4.46(1H, dd, J6,1=1.8 H
z, J2,1=6.4 Hz, H-1), 5.11(1H, dd, J3,4=11.3 Hz, J
4,5=9.0 Hz, H-4), 7.26-7.42 (9H, m, aromatic), 7.4
5-7.60(4H, m, aromatic), 7.70-7.75(2H, m, aromati
c). IR (neat) 3000, 2900, 2850, 2255, 1740, 1550, 144
0, 1410, 1360, 1270,1110, 1040, 920, 740, 700 c
m-1. [ α ]D 18 −73°(c 1.04, CHCl3).
3b : 1 H NMR (CDCl 3 ) δ: 1.10 (9H, s, (C
H 3) 3), 1.12-1.68 ( 20H, m, (CH 2) 10), 3.25 (1H, dd, J =
6.7 Hz, 16.8 Hz), 3.37 (1H, dd, J = 11.6 Hz, 16.8 H
z), 3.58 (1H, dd, J 2,3 = 7.6 Hz, J 3,4 = 11.3 Hz, H-3),
3.89 (1H, dd, J 4,5 = 9.0 Hz, J 5 , 6 = 5.8 Hz, H-5), 4.25-
4.38 (3H, m, H-2.6, ring), 4.46 (1H, dd, J 6,1 = 1.8 H
z, J 2,1 = 6.4 Hz, H-1), 5.11 (1H, dd, J 3,4 = 11.3 Hz, J
4,5 = 9.0 Hz, H-4), 7.26-7.42 (9H, m, aromatic), 7.4
5-7.60 (4H, m, aromatic), 7.70-7.75 (2H, m, aromati
c). IR (neat) 3000, 2900, 2850, 2255, 1740, 1550, 144
0, 1410, 1360, 1270, 1110, 1040, 920, 740, 700 c
m −1 . [α] D 18 −73 ° (c 1.04, CHCl 3 ).

【0043】(合成例6)イソオキサゾリン誘導体(1)及び(3)の合成(但
し、R1 ;Sit-BuMe2 ,R2 ;t-Bu) (合成例4)で合成したアクリルエステル誘導体(48mg,
0.076mmol) およびt−ブチルヒドロキシム酸クロリド
(51.4mg, 0.38mmol)ベンゼン溶液(5ml) に室温でトリエ
チルアミン(53 μl, 0.38mmol)のベンゼン溶液(5ml) を
加え、室温で2.0時間攪拌する。10%KHSO4
溶液を加え、反応を停止した。水層を酢酸エチルで抽出
し、有機層を飽和食塩水で洗浄した後、無水硫酸ナトリ
ウムで乾燥する。乾燥剤を炉別した後、溶媒を留去し、
得られた油状物をシリカゲル薄層クロマトグラフィー
(酢酸エチル:ヘキサン=1:6,2回展開) により精製
し、1c(46.6mg)および3c(4.4mg) を得た。但し、1
cはイソオキサゾリン誘導体(1)、3cはイソオキサ
ゾリン誘導体(3)である。
Synthesis Example 6 Synthesis of isoxazoline derivatives (1) and (3) (however,
R 1 ; Sit-BuMe 2 , R 2 ; t-Bu) (Acrylic ester derivative (48 mg,
0.076 mmol) and t-butylhydroxychromic acid chloride
(51.4 mg, 0.38 mmol) Benzene solution (5 ml) was added with benzene solution (5 ml) of triethylamine (53 μl, 0.38 mmol) at room temperature and stirred at room temperature for 2.0 hours. The reaction was stopped by adding 10% KHSO 4 aqueous solution. The aqueous layer is extracted with ethyl acetate, the organic layer is washed with saturated brine and then dried over anhydrous sodium sulfate. After separating the desiccant from the oven, the solvent is distilled off,
The obtained oil was purified by silica gel thin layer chromatography (ethyl acetate: hexane = 1: 6, developed twice) to give 1c (46.6 mg) and 3c (4.4 mg). However, 1
c is an isoxazoline derivative (1) and 3c is an isoxazoline derivative (3).

【0044】1c: 1H NMR (CDCl3) δ: 1.09(9H, s, (C
H3)3), 1.20(9H, s, (CH3)3), 1.22-1.80(20H, m, (C
H2)10), 2.86(1H, dd, J=17.1 Hz, 11.3 Hz), 3.12(1H,
dd, J=17.1 Hz, 5.5 Hz), 3.61(1H, dd, J2,3=7.6 Hz,
J3,4=11.3 Hz, H-3), 3.94(1H, dd, J=5.5 Hz, 11.3 H
z), 3.95(1H, dd, J4,5=8.6 Hz, J5,6=5.8 Hz, H-5),
4.30(1H, dd, J6,1=2.4 Hz, J5,6=5.8 Hz, H-6), 4.33
(1H, dd, J2,1=6.1 Hz, J2 ,3=7.6 Hz, H-2), 4.46(1H,
dd, J6,1=2.4 Hz, J2,1=6.1 Hz, H-1), 5.10(1H, dd, J
3,4=11.3 Hz, J4,5=9.0 Hz, H-4), 7.31-7.49 (6H, m,
aromatic), 7.55-7.63(2H, m, aromatic), 7.84-7.93(2
H, m, aromatic). IR (neat) 2970, 2950, 2900, 2260, 1740, 1580, 155
0, 1440, 1420, 1360,1260, 1100, 1040, 930, 700 cm
-1.
1c : 1 H NMR (CDCl 3 ) δ: 1.09 (9H, s, (C
H 3) 3), 1.20 ( 9H, s, (CH 3) 3), 1.22-1.80 (20H, m, (C
H 2 ) 10 ), 2.86 (1H, dd, J = 17.1 Hz, 11.3 Hz), 3.12 (1H,
dd, J = 17.1 Hz, 5.5 Hz), 3.61 (1H, dd, J 2,3 = 7.6 Hz,
J 3,4 = 11.3 Hz, H-3), 3.94 (1H, dd, J = 5.5 Hz, 11.3 H
z), 3.95 (1H, dd, J 4,5 = 8.6 Hz, J 5,6 = 5.8 Hz, H-5),
4.30 (1H, dd, J 6,1 = 2.4 Hz, J 5,6 = 5.8 Hz, H-6), 4.33
(1H, dd, J 2,1 = 6.1 Hz, J 2 , 3 = 7.6 Hz, H-2), 4.46 (1H,
dd, J 6,1 = 2.4 Hz, J 2,1 = 6.1 Hz, H-1), 5.10 (1H, dd, J
3,4 = 11.3 Hz, J 4,5 = 9.0 Hz, H-4), 7.31-7.49 (6H, m,
aromatic), 7.55-7.63 (2H, m, aromatic), 7.84-7.93 (2
H, m, aromatic). IR (neat) 2970, 2950, 2900, 2260, 1740, 1580, 155
0, 1440, 1420, 1360, 1260, 1100, 1040, 930, 700 cm
-1 .

【0045】3c: 1H NMR (CDCl3) δ: 1.06(9H, s, (C
H3)3), 1.14(9H, s, (CH3)3), 1.20-1.80(20H, m, (C
H2)10), 2.95(1H, dd, J=6.4 Hz, 17.1 Hz), 3.05(1H,
dd, J=11.3 Hz, 17.1 Hz), 3.55(1H, dd, J3,4=11.0 H
z, J2,3=7.6 Hz, H-3), 3.84(1H, dd, J5,4=8.9 Hz, J
5,6=5.8 Hz, H-5), 3.95(1H, dd, J=6.4 Hz, 11.3 Hz),
4.29(1H, dd, J6,1=2.1 Hz, J6,5=5.8 Hz, H-6), 4.32
(1H, dd, J2,1=6.1 Hz, J2 ,3=7.6 Hz, H-2), 4.46(1H,
dd, J6,1=2.1 Hz, J2,1=6.1 Hz, H-1), 5.09(1H, dd, J
3,4=11.0 Hz, J4,5=8.9 Hz, H-4), 7.31-7.45 (6H, m,
aromatic), 7.49-7.56(2H, m, aromatic), 7.69-7.75(2
H, m, aromatic). IR (nujol) 2950, 2900, 1730, 1580, 1440, 1370, 126
0, 1200, 1150, 1090,1040, 900, 760, 720, 690 cm-1.
3c : 1 H NMR (CDCl 3 ) δ: 1.06 (9H, s, (C
H 3) 3), 1.14 ( 9H, s, (CH 3) 3), 1.20-1.80 (20H, m, (C
H 2 ) 10 ), 2.95 (1H, dd, J = 6.4 Hz, 17.1 Hz), 3.05 (1H,
dd, J = 11.3 Hz, 17.1 Hz), 3.55 (1H, dd, J 3,4 = 11.0 H
z, J 2,3 = 7.6 Hz, H-3), 3.84 (1H, dd, J 5,4 = 8.9 Hz, J
5,6 = 5.8 Hz, H-5), 3.95 (1H, dd, J = 6.4 Hz, 11.3 Hz),
4.29 (1H, dd, J 6,1 = 2.1 Hz, J 6,5 = 5.8 Hz, H-6), 4.32
(1H, dd, J 2,1 = 6.1 Hz, J 2 , 3 = 7.6 Hz, H-2), 4.46 (1H,
dd, J 6,1 = 2.1 Hz, J 2,1 = 6.1 Hz, H-1), 5.09 (1H, dd, J
3,4 = 11.0 Hz, J 4,5 = 8.9 Hz, H-4), 7.31-7.45 (6H, m,
aromatic), 7.49-7.56 (2H, m, aromatic), 7.69-7.75 (2
H, m, aromatic). IR (nujol) 2950, 2900, 1730, 1580, 1440, 1370, 126
0, 1200, 1150, 1090, 1040, 900, 760, 720, 690 cm -1 .

【0046】(合成例7)(S)−5−ヒドロキシメチル−3−フェニル−2−イ
ソオキサゾリンの合成 (合成例4)で合成したオキサゾリン誘導体1a(80mg,
0.127mmol) のTHF溶液(2.0ml) にL-Selectride(1.0
M THF solution 0.57ml)を加え、室温で終夜攪拌する。
1N-HCl(2.0ml) を加え、反応を停止した。水層をエーテ
ルで抽出し、有機層を飽和NaHCO3 水溶液、飽和食
塩水で順次洗浄し、無水硫酸ナトリウムで乾燥した後、
溶媒を留去しえられた油状物をシリカゲルカラムクロマ
トグラフィー(酢酸エチル:ヘキサン=1:2)により精
製、標記化合物(20mg, 収率89%)を得た。
(Synthesis example 7) (S) -5-hydroxymethyl-3-phenyl-2-i
Oxazoline derivative 1a (80 mg, synthesized in Synthesis of Soxazoline (Synthesis Example 4))
0.127 mmol) in THF (2.0 ml) with L-Selectride (1.0
M THF solution (0.57 ml) is added, and the mixture is stirred at room temperature overnight.
The reaction was stopped by adding 1N-HCl (2.0 ml). The aqueous layer was extracted with ether, the organic layer was washed successively with saturated aqueous NaHCO 3 solution and saturated brine, dried over anhydrous sodium sulfate,
The oily substance obtained by distilling off the solvent was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 2) to obtain the title compound (20 mg, yield 89%).

【0047】1H NMR (CDCl3) δ: 3.28(1H, dd, J=7.9
Hz, 16.5 Hz, H=4), 3.39(1H, dd,J=10.4 Hz, 16.5 H
z, H-4), 3.68(1H, dd, J=4.6 Hz, J=12.2 Hz, H-6),
3.88(1H, dd, J=3.1 Hz, 12.2 Hz, H-6'), 4.87(1H, dd
dd, J=3.1 Hz, 4.6 Hz, 7.9 Hz, 10.4 Hz, H-5). [ α ]D 20 + 145°(c 2.0, CHCl3) (lit.R-isomer:
[ α ]D 25 − 161°(c 1.0, CHCl3) D.P.Curran Tet
rahedran Lett., 29 No.29 pp 3555〜2558, 1988)
1 H NMR (CDCl 3 ) δ: 3.28 (1H, dd, J = 7.9
Hz, 16.5 Hz, H = 4), 3.39 (1H, dd, J = 10.4 Hz, 16.5 H
z, H-4), 3.68 (1H, dd, J = 4.6 Hz, J = 12.2 Hz, H-6),
3.88 (1H, dd, J = 3.1 Hz, 12.2 Hz, H-6 '), 4.87 (1H, dd
dd, J = 3.1 Hz, 4.6 Hz, 7.9 Hz, 10.4 Hz, H-5). [α] D 20 + 145 ° (c 2.0, CHCl 3 ) (lit.R-isomer:
[α] D 25 − 161 ° (c 1.0, CHCl 3 ) DP Curran Tet
(rahedran Lett., 29 No. 29 pp 3555-2558, 1988)

【0048】同様な方法で、(合成例4)で合成した3
a、(合成例5)で合成した3bより(R)−5−ヒド
ロキシメチル−3−フェニル−2−イソオキサゾリンを
合成した。又(合成例5)で合成した1bより標記化合
物を合成した。
3 synthesized in (Synthesis example 4) by the same method
(R) -5-hydroxymethyl-3-phenyl-2-isoxazoline was synthesized from a and 3b synthesized in (Synthesis example 5). Also, the title compound was synthesized from 1b synthesized in (Synthesis Example 5).

【0049】以上の合成例から、光学活性な5−ヒドロ
キシメチル−2−イソオキサゾリン類の製造法、各中間
体の物性等が明確にされたが、更にアクリルエステル誘
導体にニトリルオキシドを付加せしめてイソオキサゾリ
ン誘導体を生成させる際のジアステレオマー選択性を明
確にする目的で、表2に反応条件とジアステレオマー選
択性の関係を示す。
From the above synthesis examples, the method for producing optically active 5-hydroxymethyl-2-isoxazolines, the physical properties of each intermediate, and the like were clarified. Further, nitrile oxide was added to the acrylic ester derivative. For the purpose of clarifying the diastereomer selectivity when producing an isoxazoline derivative, Table 2 shows the relationship between the reaction conditions and the diastereomer selectivity.

【0050】[0050]

【表1】 [Table 1]

【0051】[0051]

【発明の効果】本発明によれば光学活性の5−ヒドロキ
シメチル−2−オキザリン類、特に(S)−5−ヒドロ
キシメチル−2−イソオキサゾリン類を効率良く簡便に
製造することができる。
INDUSTRIAL APPLICABILITY According to the present invention, optically active 5-hydroxymethyl-2-oxarines, particularly (S) -5-hydroxymethyl-2-isoxazolines, can be efficiently and simply produced.

【手続補正書】[Procedure amendment]

【提出日】平成4年4月6日[Submission date] April 6, 1992

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】請求項1[Name of item to be corrected] Claim 1

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【化1】 (但しここでRは−SiRで示される有機シリル基
で、Rはアルキル基又は芳香族基であり、Rはアルキ
ル基又は芳香族基である) 還元することを特徴とする下記構造式(2)で示される
(S)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法。
[Chemical 1] (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group.) The following structure characterized by reduction: A method for producing (S) -5-hydroxymethyl-2-isoxazolines represented by formula (2).

【化2】 [Chemical 2]

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】請求項2[Name of item to be corrected] Claim 2

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【化3】 (但しここでRは−SiRで示される有機シリル基
で、Rはアルキル基又は芳香族基であり、Rはアルキ
ル基又は芳香族基である) 還元することを特徴とする構造式(4)で示される
(R)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法。
[Chemical 3] (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group.) Structural formula characterized by reduction A method for producing (R) -5-hydroxymethyl-2-isoxazolines represented by (4).

【化4】 [Chemical 4]

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】請求項3[Name of item to be corrected] Claim 3

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【化5】 [Chemical 5]

【化6】 (但しここでRは−SiRで示される有機シリル基
で、Rはアルキル基又は芳香族基であり、Rはアルキ
ル基又は芳香族基である)
[Chemical 6] (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group.)

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0006[Correction target item name] 0006

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0006】[0006]

【発明の構成】本発明によれば、下記構造式(1)で示
されるイソオキサゾリン誘導体を
According to the present invention, an isoxazoline derivative represented by the following structural formula (1)

【化9】 (但しここでRは−SiRで示される有機シリル基
で、Rはアルキル基又は芳香族基であり、Rはアルキ
ル基又は芳香族基である。以下の構造式に於いても同意
である。)。 還元することを特徴とする下記構造式(2)で示される
(S)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法
[Chemical 9] (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group. The same applies to the following structural formulas. It is.). A method for producing (S) -5-hydroxymethyl-2-isoxazolines represented by the following structural formula (2), which comprises reducing

【化10】 及び、下記構造式(3)で示されるイソオキサゾリン誘
導体を
[Chemical 10] And an isoxazoline derivative represented by the following structural formula (3)

【化11】 還元することを特徴とする構造式(4)で示される
(R)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法が提供される。
[Chemical 11] There is provided a method for producing (R) -5-hydroxymethyl-2-isoxazolines represented by structural formula (4), which comprises reducing.

【化12】 [Chemical 12]

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】下記構造式(1)で示されるイソオキサゾ
リン誘導体を 【化1】 (但しここでR1 は−SiR3 で示される有機シリル基
で、Rはアルキル基又は芳香族基であり、R2 はアルキ
ル基又は芳香族基である) 還元することを特徴とする下記構造式(2)で示される
(S)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法。 【化2】
1. An isoxazoline derivative represented by the following structural formula (1): (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group.) The following structure characterized by reduction: A method for producing (S) -5-hydroxymethyl-2-isoxazolines represented by formula (2). [Chemical 2]
【請求項2】下記構造式(3)で示されるイソオキサゾ
リン誘導体を 【化3】 (但しここでR1 は−SiR3 で示される有機シリル基
で、Rはアルキル基又は芳香族基であり、R2 はアルキ
ル基又は芳香族基である) 還元することを特徴とする構造式(4)で示される
(R)−5−ヒドロキシメチル−2−イソオキサゾリン
類の製造方法。 【化4】
2. An isoxazoline derivative represented by the following structural formula (3): (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group.) Structural formula characterized by reduction A method for producing (R) -5-hydroxymethyl-2-isoxazolines represented by (4). [Chemical 4]
【請求項3】下記構造式(1)又は(3)で示されるイ
ソオキサゾリン誘導体。 【化5】 【化6】 (但しここでR1 は−SiR3 で示される有機シリル基
で、Rはアルキル基又は芳香族基であり、R2 はアルキ
ル基又は芳香族基である)
3. An isoxazoline derivative represented by the following structural formula (1) or (3). [Chemical 5] [Chemical 6] (However, R 1 is an organic silyl group represented by —SiR 3 , R is an alkyl group or an aromatic group, and R 2 is an alkyl group or an aromatic group.)
【請求項4】下記構造式(5)で示されるアクリルエス
テル誘導体に 【化7】 (ここで、R1 は−SiR3 で示される有機シリル基
で、Rはアルキル基又は芳香族基である) R2 −C≡N+ −O- で示されるニトリルオキシド(こ
こでR2 はアルキル基又は芳香族基である)を反応させ
ることを特徴とする請求項(3)に記載の構造式(1)
又は(3)で示されるイソオキサゾリン誘導体の製造方
法。
4. An acrylic ester derivative represented by the following structural formula (5): (Here, R 1 is an organic silyl group represented by —SiR 3 , and R is an alkyl group or an aromatic group.) R 2 —C≡N + —O A nitrile oxide represented by (where R 2 is The structural formula (1) according to claim (3), wherein an alkyl group or an aromatic group is reacted.
Alternatively, a method for producing the isoxazoline derivative represented by (3).
【請求項5】下記構造式(5)で示されるアクリルエス
テル誘導体。 【化8】 (ここで、R1 は−SiR3 で示される有機シリル基
で、Rはアルキル基又は芳香族基である)
5. An acrylic ester derivative represented by the following structural formula (5). [Chemical 8] (Here, R 1 is an organic silyl group represented by —SiR 3 , and R is an alkyl group or an aromatic group.)
JP4117692A 1992-02-27 1992-02-27 Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor Withdrawn JPH05239040A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4117692A JPH05239040A (en) 1992-02-27 1992-02-27 Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4117692A JPH05239040A (en) 1992-02-27 1992-02-27 Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor

Publications (1)

Publication Number Publication Date
JPH05239040A true JPH05239040A (en) 1993-09-17

Family

ID=12601125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4117692A Withdrawn JPH05239040A (en) 1992-02-27 1992-02-27 Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor

Country Status (1)

Country Link
JP (1) JPH05239040A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131160A (en) * 1999-10-29 2001-05-15 Tosoh Corp New oxazolidinone derivative and its use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131160A (en) * 1999-10-29 2001-05-15 Tosoh Corp New oxazolidinone derivative and its use

Similar Documents

Publication Publication Date Title
HU207288B (en) Process for enenthioselective producing phenyl-isoserine derivatives
WO1992022560A1 (en) Optically active intermediate and production thereof
JP2003521546A (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
JPH05239040A (en) Production of 5-hydroxymethyl-2-isoxyzoline compound and intermediate therefor
CA2435371A1 (en) Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
CN114315696A (en) Synthesis method of 5-acyl aromatic ring carbazole compound
Uemura et al. Efficient stereoselective synthesis of a 1-hydroxymethyl-2-methylglycidol derivative
Abenhaim et al. Asymmetric synthesis using chiral lithium alkoxytrialkylaluminates: Obtention of (2S)-2-hydroxy-2-phenyl-4-methylpentanoic acid with 85% optical purity
US4808340A (en) Process for preparing methyl 4-oxo-5-tetradecynoate
JP3965704B2 (en) Process for producing optically active 5-hydroxy-3-oxo-6-heptynoic acid ester derivative
JP2002080431A (en) Octafluorotricyclodecane derivative and method for producing the same
US5359110A (en) Process for the preparation of a R-alpha cyclopentenones and R-alpha and R-omega cyclopentanoids
JPH0247470B2 (en) INDOMETASHINJUDOTAI
JP2958835B2 (en) Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative
KR800001263B1 (en) Process for the preparation of prostaglandin
JP3549567B2 (en) Method for producing optically active scandium complex and optically active cyclic compound
JP3655939B2 (en) Novel process for the preparation of 13-alkyl milbemycin intermediates
CN117209375A (en) Preparation method of polysubstituted chiral adipic acid compound containing quaternary carbon center
JP3059475B2 (en) Method for producing 2-azetidinone derivative
JP3050104B2 (en) Novel method for producing 1-butyne-3,4-diol
JPH07247241A (en) New production of carboxylic acid ester
JPH05247082A (en) Production of 2&#39;-fluoro-2&#39;,3&#39;-dideoxynucleoside and intermediate thereof
JP2002226431A (en) Method for producing liquid crystalline compound
JPH0114916B2 (en)
JPH07233175A (en) Asymmetric production of metal-substituted cyclopropylmethanol derivative.

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19990518